Key facts
- This page summarizes Hsu Ming Tsan's Form 3 filing for Jyong Biotech Ltd. (MENS).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 01 Apr 2026, 15:43.
Hsu Ming Tsan - 01 Apr 2026 Form 3 Insider Report for Jyong Biotech Ltd. (MENS)
- Reporting relationship
- Director
- Issuer ticker
- MENS
- Reported as of
- 01 Apr 2026
- Net transaction value
- $0
- Reporting owner signature
- Hsu Ming Tsan
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Hsu Ming Tsan filed Form 3 for Jyong Biotech Ltd. (MENS) on 01 Apr 2026.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reporting Owners (1)
CIK 0002125601
Primary reporting owner
Hsu Ming Tsan
- Relationship
- Director
- Address
- 23F-3, NO.95, SEC. 1, XINTAI 5TH RD., NEW TAIPEI CITY, TAIWAN
- Signature
- Hsu Ming Tsan
- Signature date
- 01 Apr 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
MENS
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 3,000
- Date
- 01 Apr 2026
- Ownership
- Direct
* marks a reported price that did not pass the local price check.